Literature DB >> 23236389

Diabetic patients with severe sepsis admitted to intensive care unit do not fare worse than non-diabetic patients: a nationwide population-based cohort study.

Cheng-Wei Chang1, Victor C Kok, Ta-Chien Tseng, Jorng-Tzong Horng, Chun-Eng Liu.   

Abstract

BACKGROUND: We sought to examine whether type 2 diabetes increases the risk of acute organ dysfunction and of hospital mortality following severe sepsis that requires admission to an intensive care unit (ICU).
METHODS: Nationwide population-based retrospective cohort study of 16,497 subjects with severe sepsis who had been admitted for the first time to an ICU during the period of 1998-2008. A diabetic cohort (n = 4573) and a non-diabetic cohort (n = 11924) were then created. Relative risk (RR) of organ dysfunctions, length of hospital stay (LOS), 90-days hospital mortality, ICU resource utilization and hazard ratio (HR) of mortality adjusted for age, gender, Charlson-Deyo comorbidity index score, surgical condition and number of acute organ dysfunction, were compared across patients with severe sepsis with or without diabetes.
RESULTS: Diabetic patients with sepsis had a higher risk of developing acute kidney injury (RR, 1.54; 95% confidence interval (CI), 1.44-1.63) and were more likely to be undergoing hemodialysis (15.55% vs. 7.24%) in the ICU. However, the diabetic cohort had a lower risk of developing acute respiratory dysfunction (RR = 0.96, 0.94-0.97), hematological dysfunction (RR = 0.70, 0.56-0.89), and hepatic dysfunction (RR = 0.77, 0.63-0.93). In terms of adjusted HR for 90-days hospital mortality, the diabetic patients with severe sepsis did not fare significantly worse when afflicted with cardiovascular, respiratory, hepatic, renal and/or neurologic organ dysfunction and by numbers of organ dysfunction. There was no statistically significant difference in LOS between the two cohorts (median 17 vs. 16 days, interquartile range (IQR) 8-30 days, p = 0.11). Multiple logistic regression analysis to predict the occurrence of mortality shows that being diabetic was not a predictive factor with an odds ratio of 0.972, 95% CI 0.890-1.061, p = 0.5203.
INTERPRETATION: This large nationwide population-based cohort study suggests that diabetic patients do not fare worse than non-diabetic patients when suffering from severe sepsis that requires ICU admission.

Entities:  

Mesh:

Year:  2012        PMID: 23236389      PMCID: PMC3517561          DOI: 10.1371/journal.pone.0050729

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  37 in total

Review 1.  Endothelial dysfunction, inflammation and diabetes.

Authors:  Paresh Dandona; Ahmad Aljada; Ajay Chaudhuri; Priya Mohanty
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

2.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases.

Authors:  R A Deyo; D C Cherkin; M A Ciol
Journal:  J Clin Epidemiol       Date:  1992-06       Impact factor: 6.437

3.  Accuracy of diabetes diagnosis in health insurance claims data in Taiwan.

Authors:  Cheng-Ching Lin; Mei-Shu Lai; Ci-Yong Syu; Shuan-Chuan Chang; Fen-Yu Tseng
Journal:  J Formos Med Assoc       Date:  2005-03       Impact factor: 3.282

4.  Impaired leucocyte functions in diabetic patients.

Authors:  M Delamaire; D Maugendre; M Moreno; M C Le Goff; H Allannic; B Genetet
Journal:  Diabet Med       Date:  1997-01       Impact factor: 4.359

5.  Diabetes induces rapid suppression of adaptive immunity followed by homeostatic T-cell proliferation.

Authors:  B Luo; W F N Chan; S J Lord; S A Nanji; R V Rajotte; A M J Shapiro; C C Anderson
Journal:  Scand J Immunol       Date:  2007-01       Impact factor: 3.487

6.  A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.

Authors:  M E Charlson; P Pompei; K L Ales; C R MacKenzie
Journal:  J Chronic Dis       Date:  1987

7.  Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats.

Authors:  Dong Liu; Bang-Xiong Zeng; Shi-Hai Zhang; Yue-Lan Wang; Lian Zeng; Zhi-Long Geng; Shi-Fan Zhang
Journal:  Crit Care Med       Date:  2005-10       Impact factor: 7.598

8.  Reversal of the toxic effects of cachectin by concurrent insulin administration.

Authors:  D L Fraker; M J Merino; J A Norton
Journal:  Am J Physiol       Date:  1989-06

9.  Prior statin therapy is associated with a decreased rate of severe sepsis.

Authors:  Yaniv Almog; Alexander Shefer; Victor Novack; Nimrod Maimon; Leonid Barski; Miruna Eizinger; Michael Friger; Lior Zeller; Abraham Danon
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

10.  Diabetes mellitus and bacteraemia: a comparative study between diabetic and non-diabetic patients.

Authors:  J A Carton; J A Maradona; F J Nuño; R Fernandez-Alvarez; F Pérez-Gonzalez; V Asensi
Journal:  Eur J Med       Date:  1992-09
View more
  15 in total

1.  The Japanese Clinical Practice Guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  J Intensive Care       Date:  2018-08-13

Review 2.  The Japanese clinical practice guideline for acute kidney injury 2016.

Authors:  Kent Doi; Osamu Nishida; Takashi Shigematsu; Tomohito Sadahiro; Noritomo Itami; Kunitoshi Iseki; Yukio Yuzawa; Hirokazu Okada; Daisuke Koya; Hideyasu Kiyomoto; Yugo Shibagaki; Kenichi Matsuda; Akihiko Kato; Terumasa Hayashi; Tomonari Ogawa; Tatsuo Tsukamoto; Eisei Noiri; Shigeo Negi; Koichi Kamei; Hirotsugu Kitayama; Naoki Kashihara; Toshiki Moriyama; Yoshio Terada
Journal:  Clin Exp Nephrol       Date:  2018-10       Impact factor: 2.801

3.  Effects of statins on incident dementia in patients with type 2 DM: a population-based retrospective cohort study in Taiwan.

Authors:  Jui-Ming Chen; Cheng-Wei Chang; Tzu-Hao Chang; Chi-Chang Hsu; Jorng-Tzong Horng; Wayne H-H Sheu
Journal:  PLoS One       Date:  2014-02-10       Impact factor: 3.240

4.  Gout as a risk factor for osteoporosis: epidemiologic evidence from a population-based longitudinal study involving 108,060 individuals.

Authors:  V C Kok; J-T Horng; M N Wang; Z-Y Chen; J-T Kuo; G-D Hung
Journal:  Osteoporos Int       Date:  2018-01-30       Impact factor: 4.507

5.  Association of diabetes and diabetes treatment with the host response in critically ill sepsis patients.

Authors:  Lonneke A van Vught; Brendon P Scicluna; Arie J Hoogendijk; Maryse A Wiewel; Peter M C Klein Klouwenberg; Olaf L Cremer; Janneke Horn; Peter Nürnberg; Marc M J Bonten; Marcus J Schultz; Tom van der Poll
Journal:  Crit Care       Date:  2016-08-06       Impact factor: 9.097

6.  Mean Daily Dosage of Aspirin and the Risk of Incident Alzheimer's Dementia in Patients with Type 2 Diabetes Mellitus: A Nationwide Retrospective Cohort Study in Taiwan.

Authors:  Cheng-Wei Chang; Jorng-Tzong Horng; Chi-Chang Hsu; Jui-Ming Chen
Journal:  J Diabetes Res       Date:  2016-10-27       Impact factor: 4.011

7.  Association of In-Hospital Mortality and Dysglycemia in Septic Patients.

Authors:  Hsiao-Yun Chao; Peng-Hui Liu; Shen-Che Lin; Chun-Kuei Chen; Jih-Chang Chen; Yi-Lin Chan; Chin-Chieh Wu; Gerald N Blaney; Zhen-Ying Liu; Cho-Ju Wu; Kuan-Fu Chen
Journal:  PLoS One       Date:  2017-01-20       Impact factor: 3.240

8.  Allopurinol therapy in gout patients does not associate with beneficial cardiovascular outcomes: a population-based matched-cohort study.

Authors:  Victor C Kok; Jorng-Tzong Horng; Wan-Shan Chang; Ya-Fang Hong; Tzu-Hao Chang
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

9.  Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis.

Authors:  Victor C Kok; Jorng-Tzong Horng; Jing-Long Huang; Kuo-Wei Yeh; Jia-Jing Gau; Cheng-Wei Chang; Lai-Zhen Zhuang
Journal:  BMC Cancer       Date:  2014-08-29       Impact factor: 4.430

10.  The Expression of Programmed Death-1 on CD4+ and CD8+ T Lymphocytes in Patients with Type 2 Diabetes and Severe Sepsis.

Authors:  Yumei Jia; Yongzhen Zhao; Chunsheng Li; Rui Shao
Journal:  PLoS One       Date:  2016-07-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.